Food effect on tofacitinib MR pharmacokinetics

Phase 1, randomised, open-label trial of tofacitinib oral solution in rheumatoid arthritis (RA) (2 arms), sponsored by Pfizer. Primary endpoints: Area under the curve from time zero to infinity, Area under the plasma concentration-time profile from time zero to time of the last quantifiable concentration and 1 more. Started Apr 2014; status: completed.